ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$32.88
−0.12%Margins
Gross margin
-5972.6%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-196.0%
Return on equity
-69.0%
Return on assets
-74.7%
Return on invested capital
0.00x
Asset turnover
-$226.0M
Cash from operations
$9.87
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026